142 related articles for article (PubMed ID: 33790390)
21. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
22. JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expression.
Su Y; Yu QH; Wang XY; Yu LP; Wang ZF; Cao YC; Li JD
BMC Cancer; 2017 Jul; 17(1):477. PubMed ID: 28693517
[TBL] [Abstract][Full Text] [Related]
23. Identifying novel genes and chemicals related to nasopharyngeal cancer in a heterogeneous network.
Li Z; An L; Li H; Wang S; Zhou Y; Yuan F; Li L
Sci Rep; 2016 May; 6():25515. PubMed ID: 27149165
[TBL] [Abstract][Full Text] [Related]
24. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis.
Mi JL; Xu M; Liu C; Wang RS
Medicine (Baltimore); 2020 Aug; 99(32):e21505. PubMed ID: 32769887
[TBL] [Abstract][Full Text] [Related]
26. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
27. CFTR is a potential marker for nasopharyngeal carcinoma prognosis and metastasis.
Tu Z; Chen Q; Zhang JT; Jiang X; Xia Y; Chan HC
Oncotarget; 2016 Nov; 7(47):76955-76965. PubMed ID: 27769067
[TBL] [Abstract][Full Text] [Related]
28. [Common dysregulated genes and pathways in two sets of nasopharyngeal carcinoma biopsy samples from differential regions].
XIONG YY; HUANG ZX
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):414-8. PubMed ID: 21421473
[TBL] [Abstract][Full Text] [Related]
29. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
Chen Z; Long L; Wang K; Cui F; Zhu L; Tao Y; Wu Q; Xiang M; Liang Y; Qiu S; Xiao Z; Yi B
Oncotarget; 2016 Jun; 7(23):34022-37. PubMed ID: 27145374
[TBL] [Abstract][Full Text] [Related]
30. Reexploring the possible roles of some genes associated with nasopharyngeal carcinoma using microarray-based detection.
Fang WY; Liu TF; Xie WB; Yang XY; Wang S; Ren CP; Deng X; Liu QZ; Huang ZX; Li X; Ding YQ; Yao KT
Acta Biochim Biophys Sin (Shanghai); 2005 Aug; 37(8):541-6. PubMed ID: 16077901
[TBL] [Abstract][Full Text] [Related]
31. Microarray Expression Profiling of Long Non-Coding RNAs Involved in Nasopharyngeal Carcinoma Metastasis.
Wen X; Tang X; Li Y; Ren X; He Q; Yang X; Zhang J; Wang Y; Ma J; Liu N
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886062
[TBL] [Abstract][Full Text] [Related]
32. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
33. The four‑microRNA signature identified by bioinformatics analysis predicts the prognosis of nasopharyngeal carcinoma patients.
Zhang S; Yue W; Xie Y; Liu L; Li S; Dang W; Xin S; Yang L; Zhai X; Cao P; Lu J
Oncol Rep; 2019 Nov; 42(5):1767-1780. PubMed ID: 31545473
[TBL] [Abstract][Full Text] [Related]
34. An Oncogenic Role for Four-Jointed Box 1 (FJX1) in Nasopharyngeal Carcinoma.
Chai SJ; Ahmad Zabidi MM; Gan SP; Rajadurai P; Lim PVH; Ng CC; Yap LF; Teo SH; Lim KP; Patel V; Cheong SC
Dis Markers; 2019; 2019():3857853. PubMed ID: 31236144
[TBL] [Abstract][Full Text] [Related]
35. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.
Luo Z; Zhang L; Li Z; Li X; Li G; Yu H; Jiang C; Dai Y; Guo X; Xiang J; Li G
BMC Med Genomics; 2012 Jan; 5():3. PubMed ID: 22260379
[TBL] [Abstract][Full Text] [Related]
36. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
Yang Y; Li Q; Guo L
Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
[TBL] [Abstract][Full Text] [Related]
38. Omics-based identification of biomarkers for nasopharyngeal carcinoma.
Janvilisri T
Dis Markers; 2015; 2015():762128. PubMed ID: 25999660
[TBL] [Abstract][Full Text] [Related]
39. Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization.
Zhou Y; Zeng Z; Zhang W; Xiong W; Li X; Zhang B; Yi W; Xiao L; Wu M; Shen S; Li X; Cao L; Tang K; Li G
Eur J Cancer Prev; 2008 Nov; 17(6):561-71. PubMed ID: 18941378
[TBL] [Abstract][Full Text] [Related]
40. An integrative transcriptomic analysis reveals p53 regulated miRNA, mRNA, and lncRNA networks in nasopharyngeal carcinoma.
Gong Z; Yang Q; Zeng Z; Zhang W; Li X; Zu X; Deng H; Chen P; Liao Q; Xiang B; Zhou M; Li X; Li Y; Xiong W; Li G
Tumour Biol; 2016 Mar; 37(3):3683-95. PubMed ID: 26462838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
